Ascentage Pharma Group International AAPG Ratios (2023-2026)

NASDAQ AAPG
$16.55 +0.64 (+4.02%)
As of: Oct 21, 2026 · 10:06 AM EDT
Reported Financials

Ascentage Pharma Group International Quarterly Ratios

Periods 5 quarters
Latest Jun 2026

Ascentage Pharma Group International ratios data for the quarter ended Jun 2026. These financial ratios cover 5 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2023 Dec2024 Jun2025 Dec2025 Jun2026
Efficiency
Inventory AverageInventory Avg. 1.59M1.05M2.64M6.78M
Assets AverageAssets Avg. 1,765.22M
Equity AverageEquity Avg. 23.75M137.00M
Invested CapitalInvested Cap. 12.51M
Leverage & Solvency
Debt Ratio 0.01
Valuation
Price to BookP/B 12.8419.68
Enterprise Value 3,196.75M2,097.32M1,360.90M
Market Capitalization 3,428.68M2,448.99M1,638.88M

Ascentage Pharma Group International Ratios API

Pull Ascentage Pharma Group International's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AAPG&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY